Navigation Links
PEAT International Commissions Plasma-Based Waste Treatment Facility Designed Specifically for Onsite Waste Processing
Date:4/23/2008

- Marks the first deployment of the system intended for hospitals and

industrial facilities -

NORTHBROOK, Ill., and ANKLESHWAR, India, April 23 /PRNewswire/ -- PEAT International, Inc., ("PEAT") a global leader in plasma-based waste remediation solutions, announced today it has successfully commissioned its first PTDR-100 system located at the Gujarat Industrial Development Corporation near the Jayaben Modi Hospital in Ankleshwar, India. PTDR stands for Plasma Thermal Destruction and Recovery.

The 60-kilogram-per-hour (130 lb/hr) PTDR-100 system, developed to primarily treat biomedical waste and other industrial/universal waste streams, represents a first-of-its-kind system -- a permanent, fully self-contained platform for hospitals and industrial facilities.

"The PTDR-100 system is an ideal, turn-key solution for small to medium-sized waste generators looking for stable yet flexible on-site solutions to their waste management challenges," said Joseph Rosin, PEAT International Chairman. "Most importantly, the PTDR-100 matches environmental superiority with cost-competitiveness. It's efficient, it's environmentally benign and it's economical."

Using its proprietary PTDR technology, PEAT's environmentally clean process utilizes plasma torches to convert waste into a synthetic gas, comprised mainly of Carbon monoxide and Hydrogen which is a valuable source of Alternative Energy and can be used for electricity and/or hot water generation and other useful end-products. The PTDR-100 system comes equipped with a 100-kW plasma heating system.

The entire system, which can be generally be operated by just one control-panel operator, occupies just 50 square meters (under 550 square feet), sitting on two skids and standing just 4.5 meters (under 15 feet) high. There is no secondary pollution, just usable end-products generated: all feedstock is 100% waste diversion, totally eliminating the need for landfill disposal and/or further processing.

"The PTDR-100 provides generators with a best available treatment technology, deployed at their own sites, that is cost-effective, technologically and environmentally superior to any other available methods," said Jose Capote, PEAT Chief Technical Officer. "Using a PTDR-100 system allows waste generators to minimize liability issues associated with the transportation of waste streams along with potentially generating some carbon credits along the way."

Wastes processed through a PTDR-100 system typically see high volume (over 200 to 1) and weight (over 10 to 1) reductions in conjunction with a high destruction and removal efficiency of organic materials (greater than 99.9999%).

Throughout February and March, PEAT successfully processed a combination of waste streams (individually and co-mingled), including biomedical wastes, dye intermediates, various pharmaceutical industry wastes, distillation bottoms and municipal wastes over a continuous period to complete the commissioning validation tests and collect operational data that will be valuable assets for obtaining any and all future regulatory approvals.

"This technology is truly amazing," said Atul B. Buch, President of the Ankleshwar Industries Association in Gujarat, India, responsible for providing PEAT with the access to the facility site. "It destroys any and all toxic material and there is no secondary pollution. We are excited about its commercial prospects as this system can help all kinds of companies and hospitals address their current waste issues."

The PTDR technology has received numerous approvals from various regulatory agencies throughout the world, including it being listed as an approved Alternative Medical Waste Treatment Technology by the California Department of Public Health and the Michigan Department of Environmental Quality.

"This is another tremendous step forward for plasma technology as a whole," said Dr. C.B. Upasni of the Jyoti Om Chemical Research Centre, who oversaw the entire third-party testing program, which included expert oversight from academia and government regulators. Further, the Ankleshwar Environmental Preservation Society also was provided access to the test site for additional comprehensive monitoring. "The PTDR-100 system is the future of waste remediation."

About PEAT International

Founded in 2001, PEAT International is a company whose mission is the deployment of advanced waste-to-resources technologies. The company's principal mission is the deployment of its proprietary Plasma Thermal Destruction and Recovery ("PTDR") technology for the treatment of a wide range of waste feedstocks, including industrial, biological/medical, municipal and universal waste streams. Using the proprietary PTDR technology, PEAT's environmentally friendly process converts wastes into a non-toxic synthetic gas (which is a valuable source of alternative energy) and other useful end-products. The PTDR is a proven, cost-effective, environmentally clean and commercially viable solution for waste remediation. For more information on PEAT International or the PTDR-100, please contact Daniel Ripes, dripes@peat.com.tw, at 847-559-8567 or visit http://www.peat.com.


'/>"/>
SOURCE PEAT International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
3. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
4. Arrow International Files and Mails Definitive Proxy Materials
5. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Viragen International to Reverse Split Its Common Stock
8. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
9. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
10. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
11. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):